Carotid Intima-media Thickness as Cardiovascular Mortality Predictor in Peritoneal Dialysis Patients
1 other identifier
observational
57
1 country
1
Brief Summary
Cardiovascular (CV) disease is the main cause of death in patients on dialysis. The aim of this study is the long-term prognostic values of carotid intima-media thickness and coronary flow reserve in cardiovascular mortality of peritoneal dialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 17, 2016
CompletedFirst Posted
Study publicly available on registry
October 19, 2016
CompletedOctober 20, 2016
October 1, 2016
3 years
October 17, 2016
October 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diseases morbidity
10-15 years
Secondary Outcomes (1)
Patient Survival
10-15 years
Study Arms (2)
peritoneal dialysis patients
37 peritoneal dialysis patients followed at the Istanbul Medical Faculty from October 1994 to October 2011
renal transplant recipients
20 renal transplant recipients followed at the Istanbul Medical Faculty from October 1994 to October 2011 setted as the control group
Eligibility Criteria
All patients were treated by peritoneal dialysis or followed up as kidney transplant recipient at the Istanbul Medical Faculty from October 1994 to October 2011. Two groups were established for trial as peritoneal dialysis patients and renal transplant recipients. Patients had follow up shorter than six months and missing data not included in the trial
You may qualify if:
- Peritoneal dialysis patients whose followed up at least six months from October 1994 to October 2011 (for study group)
- Kidney transplant recipients whose followed up at least six months from October 1994 to October 2011 (for control group)
You may not qualify if:
- diabetes mellitus
- valvular heart disease,
- any prior coronary intervention and congestive heart failure
- Patients whose left anterior descending coronary artery (LAD) could not be visualized adequately by Doppler echocardiography were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Istanbul, 34093, Turkey (Türkiye)
Biospecimen
hemogram, serum creatinine, uric asid, calcium, phosphorus and albumin
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasar Caliskan, MD
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Study Record Dates
First Submitted
October 17, 2016
First Posted
October 19, 2016
Study Start
January 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
October 20, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share